At least three distinct FDA 510(k) clearances identified (K201232, K230575, K241837).
Clinical evidence
Vendor-supported
Not the primary source used here.
Independent
Independent validation study (Frontiers in Oncology) comparing AI contouring against multiple radiation oncologists; also presented via an NHS AI Fellowship implementation poster.
Real-world deployment
Documented clinical implementation interest via the NHS AI Fellowship program.
Interoperability
European status
Editorial verdict
Limits and uncertainties
Read the full Frontiers in Oncology study before publishing to extract exact concordance/agreement figures.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.